The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production
Open accessAbstract
The expression of the gag-pol polyprotein of human immunodeficiency virus type 1 (HIV-1) occurs via ribosomal frameshifting between the gag and pol genes. Because low levels of the gag-pol precursor are naturally produced in HIV-1-infected cells, a limited amount of information is available on the biology of this molecule. To further study this polyprotein, two mutant HIV-1 proviral genomes were created to position the gag and pol genes in the same translational reading frame. The mutations inserted a single thymidine nucleotide at the site of ribosomal frameshifting (nucleotide 1635), which results in the addition of a phenylalanine residue (frameshift 1 [FS1]), or a single adenine nucleotide, which results in the addition of a leucine residue (frameshift 2 [FS2]). Transfection of the mutant proviral genomes into COS-1 cells resulted in the expression of the p160gag-pol polyprotein precursor as well as the proteolytically processed gag and pol gene products. Metabolic labeling of the transfected cells with [3H]myristic acid revealed that the p160gag-pol and p17gag proteins expressed from the mutant genomes were myristylated. While the supernatants from COS-1 cells transfected with wild-type or mutant proviral genomes contained similar amounts of p24 antigen, the levels of reverse transcriptase were, on the average, 10 times greater in the supernatants from cells transfected with the FS1 and FS2 proviral genomes. The cells transfected with the wild-type proviral genome released infectious viral particles, while the mutant proviral genomes released p24 and reverse transcriptase in the absence of detectable particle formation. The mutant proviral genomes were completely noninfectious as determined by coculture of the transfected COS-1 cells with SupT1 cells. These results demonstrate that the gag-pol polyprotein of HIV-1 contains the appropriate signals for proteolytic processing and association with intracytoplasmic membranes in the absence of virion formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Complete nucleotide sequence of the AIDS virus, HTLV-III
Ratner, L., Haseltine, W. A., Patarca, R., Livak, K. J., Starcich, B. R., Josephs, S. F., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., et al. (1985) · Nature · doi:10.1038/313277a0 · Cited by 2,258
Active human immunodeficiency virus protease is required for viral infectivity
Kohl, N. E., Emini, E. A., Schleif, W. A., Davis, L. J., Heimbach, J. C., Dixon, R. A., Scolnick, E. M., & Sigal, I. S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4686 · Cited by 1,307
Nucleotide sequence of the AIDS virus, LAV
Wain-Hobson, S., Sonigo, P., Danos, O., Cole, S., & Alizon, M. (1985) · Cell · doi:10.1016/0092-8674(85)90303-4 · Cited by 1,202
Conserved Folding in Retroviral Proteases: Crystal Structure of Synthetic HIV-1 Protease
Wlodawer, A., Miller, M., Jaskólski, M., Sathyanarayana, B. K., Baldwin, E. T., Weber, I. T., Selk, L., Clawson, L., Schneider, J., & Kent, S. B. H. (1989) · Science · doi:10.1126/science.2548279 · Cited by 1,167
Characterization of ribosomal frameshifting in HIV-1 gag-pol expression
Jacks, T., Power, M. D., Masiarz, F. R., Luciw, P. A., Barr, P. J., & Varmus, H. E. (1988) · Nature · doi:10.1038/331280a0 · Cited by 966
Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1
Navia, M. A., Fitzgerald, P. M. D., McKeever, B. M., Leu, C., Heimbach, J. C., Herber, W. K., Sigal, I. S., Darke, P. L., & Springer, J. P. (1989) · Nature · doi:10.1038/337615a0 · Cited by 892
Lopata, M. A., Cleveland, D. W., & Sollner-Webb, B. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.14.5707 · Cited by 858
Cited by
Sorted by citations
Items 101–163 of 163
Gag-Pol Transframe Domain p6* Is Essential for HIV-1 Protease-Mediated Virus Maturation
Yu, F.-H., Chou, T.-A., Liao, W.-H., Huang, K.-J., & Wang, C.-T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127974 · Cited by 15
Suresh, S., Ahn, H. W., Joshi, K., Dakshinamurthy, A., Kannanganat, A., Garfinkel, D. J., & Farabaugh, P. J. (2015) · Mobile DNA · doi:10.1186/s13100-015-0053-5 · Cited by 15
Larrouy, L., Vivot, A., Charpentier, C., Bénard, A., Visseaux, B., Damond, F., Matheron, S., Chêne, G., Brun‐Vézinet, F., & Descamps, D. (2012) · AIDS · doi:10.1097/qad.0b013e32835a10d8 · Cited by 15
Cardno, T. S., Shimaki, Y., Sleebs, B. E., Lackovic, K., Parisot, J. P., Moss, R. M., Crowe‐McAuliffe, C., Mathew, S. F., Edgar, C. D., Kleffmann, T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139036 · Cited by 15
Yu, F.-H., Huang, K.-J., & Wang, C.-T. (2017) · Journal of Virology · doi:10.1128/jvi.00103-17 · Cited by 15
Potempa, M., Nalivaika, E. A., Ragland, D. A., Lee, S.-K., Schiffer, C. A., & Swanstrom, R. I. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.05.007 · Cited by 15
Chen, S.-W., Chiu, H.-C., Liao, W.-H., Wang, F., Chen, S. S.-L., & Wang, C.-T. (2003) · Virology · doi:10.1016/j.virol.2003.08.043 · Cited by 15
A Single Amino Acid Substitution in HIV-1 Reverse Transcriptase Significantly Reduces Virion Release
Chiang, C.-C., Wang, S.-M., Pan, Y.-Y., Huang, K.-J., & Wang, C.-T. (2009) · Journal of Virology · doi:10.1128/jvi.01532-09 · Cited by 15
Elicitation of Immunity to HIV Type 1 Gag Is Determined by Gag Structure
Young, K. R., & Ross, T. M. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.99 · Cited by 14
A Novel Self-Replicating Chimeric Lentivirus-Like Particle
Jurgens, C. K., Young, K. R., Madden, V. J., Johnson, P. R., & Johnston, R. E. (2011) · Journal of Virology · doi:10.1128/jvi.05191-11 · Cited by 13
Complementation studies with Rous sarcoma virus gag and gag-pol polyprotein mutants
Oertle, S., Bowles, N. E., & Spahr, P. F. (1992) · Journal of Virology · doi:10.1128/jvi.66.6.3873-3878.1992 · Cited by 13
In Vitro Processing of Human Immunodeficiency Virus Type 1 Gag Virus-like Particles
Morikawa, Y., Shibuya, M., Goto, T., & Sano, K. (2000) · Virology · doi:10.1006/viro.2000.0370 · Cited by 13
HIV-1 Mutant Assembly, Processing and Infectivity Expresses Pol Independent of Gag
Yu, F.-H., Huang, K.-J., & Wang, C.-T. (2020) · Viruses · doi:10.3390/v12010054 · Cited by 11
Targeting human immunodeficiency virus type 1 assembly, maturation and budding.
Wapling, J., Srivastava, S., Shehu-Xhilaga, M., & Tachedjian, G. (2007) · Europe PMC (PubMed Central) · Cited by 11
Royer, M., Tournier, J., Gay, B., Boulanger, P. A., & Bardy, M. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-1-131 · Cited by 11
An RNA pseudoknot stimulates HTLV-1 pro-pol programmed −1 ribosomal frameshifting
Thulson, E., Hartwick, E. W., Cooper‐Sansone, A., Williams, M. A. C., Soliman, M. E., Robinson, L., Kieft, J. S., & Mouzakis, K. D. (2020) · RNA · doi:10.1261/rna.070490.119 · Cited by 10
Class II Transactivator (CIITA) Enhances Cytoplasmic Processing of HIV-1 Pr55Gag
Porter, K. A., Kelley, L. N., George, A., Harton, J. A., & Duus, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011304 · Cited by 9
Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding
Wapling, J., Srivastava, S., Shehu-Xhilaga, M., & Tachedjian, G. (2007) · Drug Target Insights · doi:10.1177/117739280700200020 · Cited by 11
Lee, E.-G., Sinicrope, A., Jackson, D. L., Yu, S. F., & Linial, M. L. (2012) · Journal of Virology · doi:10.1128/jvi.06979-11 · Cited by 8
The CARD8 inflammasome in HIV infection
Clark, K. M., Pal, P., Kim, J. G., Wang, Q., & Shan, L. (2023) · Advances in immunology · doi:10.1016/bs.ai.2022.11.001 · Cited by 9
Brunelle, M., Brakier‐Gingras, L., & Lemay, G. (2003) · Journal of Virology · doi:10.1128/jvi.77.5.3345-3350.2003 · Cited by 8
Regulation of Intracellular Human Immunodeficiency Virus Type-1 Protease Activity
Gatlin, J., Arrigo, S. J., & Schmidt, M. G. (1998) · Virology · doi:10.1006/viro.1998.9083 · Cited by 8
Li, P., Stephenson, A. J., Brennan, P. A., Karageorgos, L., Kok, T., Kuiper, L. J., Swift, J. G., & Burrell, C. J. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-8-1917 · Cited by 9
Shehu-Xhilaga, M., Jy, L., Campbell, S., Marshall, J. A., Crowe, S. M., & Mak, J. (2002) · Journal of Biomedical Science · doi:10.1007/bf02254998 · Cited by 7
Interferon-Stimulated Genes that Target Retrovirus Translation
Jäger, N., Pöhlmann, S., Rodnina, M. V., & Ayyub, S. A. (2024) · Viruses · doi:10.3390/v16060933 · Cited by 9
Mechanism and Kinetics of HIV-1 Protease Activation
Tabler, C. O., & Tilton, J. C. (2024) · Viruses · doi:10.3390/v16121826 · Cited by 8
Programmed —1 Ribosomal Frameshift in the Human Immunodeficiency Virus of Type 1
Brakier‐Gingras, L., & Dulude, D. (2009) · Nucleic acids and molecular biology · doi:10.1007/978-0-387-89382-2_8 · Cited by 7
Kohoutová, Z., Rumlová, M., Andreánsky, M., Sakalian, M., Hunter, E., Pichová, I., & Ruml, T. (2008) · Virology · doi:10.1016/j.virol.2008.10.048 · Cited by 7
Development of a rapid and convenient method for the quantification of HIV-1 budding
Sakuragi, S., Sakuragi, J.-I., Morikawa, Y., & Shioda, T. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.02.027 · Cited by 7
A Large Extension to HIV-1 Gag, Like Pol, Has Negative Impacts on Virion Assembly
Haraguchi, H., Noda, T., Kawaoka, Y., & Morikawa, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047828 · Cited by 6
Help or Hinder: Protein Host Factors That Impact HIV-1 Replication
Moezpoor, M. R., & Stevenson, M. (2024) · Viruses · doi:10.3390/v16081281 · Cited by 7
Arad, G., BAR-MEIR, R., & Kotler, M. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00302-p · Cited by 6
Chiu, H.-C., Liao, W.-H., Chen, S.-W., & Wang, C.-T. (2004) · Journal of Biomedical Science · doi:10.1007/bf02254445 · Cited by 6
Determinants of Moloney Murine Leukemia Virus Gag-Pol and Genomic RNA Proportions
Johnson, S. F., Collins, J. T., D’Souza, V. M., & Telesnitsky, A. (2014) · Journal of Virology · doi:10.1128/jvi.03513-13 · Cited by 6
Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication
Jehad, M. A., Ali, L. M., Pillai, V. N., Prabhu, S. G., Mustafa, F., & Rizvi, T. A. (2026) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaf066 · Cited by 5
“…a 20:1 ratio of Gag versus Pol is essential for virus replication; any perturbation in this ratio is not tolerated by the virus, resulting in defects in replication, virion formation, and infectivity (Park and Morrow 1991 , Karacostas et al. 1993 , Shehu-Xhilaga et al. 2001 , Biswas et al. 2004 ).”
Ko, L.-J., Yu, F.-H., Huang, K.-J., & Wang, C.-T. (2015) · FEBS Open Bio · doi:10.1016/j.fob.2015.04.003 · Cited by 4
p6gag domain confers cis HIV-1 Gag-Pol assembly and release capability
Guo, T.-W., Yu, F.-H., Huang, K.-J., & Wang, C.-T. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000321 · Cited by 5
Goff, S. P. (2004) · Elsevier eBooks · doi:10.1016/b978-012764051-8/50006-8 · Cited by 4
Premature Activation of the HIV-1 Protease Is Influenced by Polymorphisms in the Hinge Region
Tabler, C. O., Wegman, S. J., Alhusaini, N., Lee, N. F., & Tilton, J. C. (2024) · Viruses · doi:10.3390/v16060849 · Cited by 3
Specific RNA–protein interactions in the replication of foamy viruses (FVs)
Rethwilm, A. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.09.003 · Cited by 3
Programmed −1 Frameshifting in Eukaryotes
Farabaugh, P. J. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5999-3_5 · Cited by 3
Nachum, G. S., Boucher, J. I., Flynn, J. M., Quansah, P., Nachum, S., & Bolon, D. N. A. (2026) · Journal of Virology · doi:10.1128/jvi.02229-25 · Cited by 2
Wood, G., Lastovka, F., Murza, D., Brember, M. P., McGovern, N. N., & Chung, B. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169371 · Cited by 2
Farabaugh, P. J. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5999-3_4 · Cited by 2
Kim, A. S., Ma, K., Reinhardt, C. J., Lazar, D. C., Ogasawara, D., Shaw, T. M., de la Torre, J. C., Bailey, A. L., Melillo, B. N., Teijaro, J. R., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2524108123
Proteolytic cleavage events in the maturation of HIV-1 reverse transcriptase
Abram, M. E. (2005) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
HIV-1 Biology at the Protein Level
Ott, D. E. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6542-7_2 · Cited by 1
Xiao, Y., Wang, R., Han, X., Wang, W., & Liang, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031766 · Cited by 1
Peptide Nucleic Acids as Epigenetic Inhibitors of HIV-1
Sei, S. (2007) · Springer eBooks · doi:10.1007/0-387-32956-0_9 · Cited by 1
CARD8 inflammasome mediates pyroptosis of HIV-1-infected cells by sensing viral protease activityPreprint
Wang, Q., Gao, H., Clark, K. M., Tang, P., Harlan, G. H., Kutluay, S. B., DeSelm, C. J., Presti, R. M., & Shan, L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.25.308734 · Cited by 1
Peptide nucleic acids as epigenetic inhibitors of HIV-1
Sei, S. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02484563 · Cited by 1
Die Rolle von p6* für den HI-viralen Replikationszyklus
Leiherer, A. (2009) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.12102
Molecular Counting in Moloney Murine Leukemia Virus Assembly.
Johnson, S. F. (2012) · Deep Blue (University of Michigan)
Larrouy, L., Brun‐Vézinet, F., & Descamps, D. (2010) · Virologie · doi:10.1684/vir.2010.0289
Sites de clivage de gag et résistance du VIH aux inhibiteurs de la protéase
Larrouy, L., Brun‐Vézinet, F., & Descamps, D. (2010) · Antibiotiques · doi:10.1016/j.antib.2010.02.004
Mechanisms and implications of programmed translational
Dinman, J. D. (2012)
Early-stage drug discovery of HIV-1 frameshifting modulators
Fernandes, A. B. (2015) · Discovery Research Portal (University of Dundee)
Recoding of viral mRNAs by –1 programmed ribosome frameshifting
Korniy, N. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7484
Peptide nucleic acids as epigenetic inhibitors of HIV-1
Sei, S. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-004-4925-7
Peptide nucleic acids as epigenetic inhibitors of HIV-1
Sei, S. (2005) · Letters in Peptide Science · doi:10.1007/s10989-005-4925-2
Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding
Wapling, J., Srivastava, S., Shehu-Xhilaga, M., & Tachedjian, G. (2007) · Drug Target Insights · doi:10.33393/dti.2007.1318
Adhikary, K., & Dey, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.13.724818
Metadata
- Authors
- Park, J., & Morrow, C. D.
- Affiliations
- University of Alabama at Birmingham (US)
- ORCID
- Morrow, C D
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 1991-09
- Volume
- 65
- Issue
- 9
- Pages
- 5111-5117
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC248980
- OpenAlex
- W2099481042
- Cited by
- 163
- References
- 35
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 6 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 3 · 2017: 3 · 2016: 3 · 2015: 10 · 2014: 2 · 2013: 2 · 2012: 11
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01ai027290-05)
- National Cancer Institute (CA-13 148, P30CA013148)
- National Institute of Allergy and Infectious Diseases (AI 27290, AI-27767, P30AI027767)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- ribosomal frameshifting, proteolytic processing, myristoylation, reverse transcriptase, p24 antigen, viral assembly
- MeSH terms
- Amino Acid Sequence, Base Sequence, DNA Mutational Analysis, Molecular Sequence Data, Morphogenesis, Oligonucleotides, Protein Processing, Post-Translational, Proteins, Recombinant Proteins, Structure-Activity Relationship, HIV-1, Gene Products, gag, Gene Products, pol, Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
